Cure SMA Announces Biogen as Presenting Sponsor for the 2016 Annual SMA Conference

Leave a Comment / Conference, Front Page News /

Cure SMA is pleased to announce that Biogen will be the Presenting Sponsor for our 2016 Annual SMA Conference. This year’s conference is set to be a significant event for the SMA community, with over 1,400 families and researchers coming together in Disneyland, June 16-19. “Without the generosity and support of Biogen, it would not […]

Cure SMA Announces Biogen as Presenting Sponsor for the 2016 Annual SMA Conference Read More »

Cure SMA Releases June 2016 Update to the SMA Drug Pipeline

Leave a Comment / Clinical Trials, Front Page News, Our Impact, Research /

We’ve recently released an update to the SMA drug pipeline. This latest version includes: 18 active programs. 14 pharmaceutical partners. 6 programs in clinical trials. 28 programs in the cumulative pipeline total, including 10 failures to date. An ever-increasing breadth of potential treatment approaches to SMA. Effective Treatments for All Ages, Stages and Types of

Cure SMA Releases June 2016 Update to the SMA Drug Pipeline Read More »

Thank you to Our 2016 Annual SMA Conference Exhibitors!

Leave a Comment / Conference, Front Page News /

Thank you to the following exhibitors who have generously supported our 2016 Annual SMA Conference. This one-of-a-kind event would not be possible without your support! For more information on any of these companies, please visit our conference exhibitor page. Conference Exhibitors Platinum Exhibitors Gold Exhibitors Gunnell, Inc. Innovation In Motion PromptCare RespirTechThomashilfen North America Triumph

Thank you to Our 2016 Annual SMA Conference Exhibitors! Read More »

Biogen and Ionis Release Spring 2016 Community Update

Leave a Comment / Clinical Trials, Front Page News /

Biogen and Ionis Pharmaceuticals recently provided an update on the clinical development of nusinersen (IONIS-SMNRx), which is currently being tested in Phase 3 clinical trials: Dear members of the SMA community, As we approach the upcoming Cure SMA conference in Anaheim, we want to provide an update on the status of the nusinersen program and

Biogen and Ionis Release Spring 2016 Community Update Read More »

2016 Annual SMA Conference Booklet Now Posted

Leave a Comment / Conference, Front Page News /

The 2016 Annual SMA Conference Booklet has been posted. The booklet includes: A complete schedule with information about the special events we’ve got planned for each evening including: the Meet and Greet and Family Fun Fest, the Family Friendly Research Poster Session, and Saturday Night at Disneyland Park! Information on Saturday afternoon’s panels focusing on

2016 Annual SMA Conference Booklet Now Posted Read More »

Update on the Clinical Development of LMI070

Leave a Comment / Clinical Trials, Front Page News /

Novartis recently provided the following update on clinical trials for LMI070, an orally available SMA drug that corrects SMN2 splicing: “We have made the difficult decision to pause enrollment for our study of LMI070 for the treatment of Type 1 Spinal Muscular Atrophy (SMA). Animal safety studies were taking place in parallel with this trial,

Update on the Clinical Development of LMI070 Read More »

Spring 2016 Issue of Compass Now Available

Leave a Comment / Front Page News, Our Impact, Research /

The Spring 2016 issue of Compass is now available online. As part of our most recent round of funding, we’ve announced eight grants totaling $890,000 for basic research, and two grants totaling $100,000 for clinical care research. This issue introduces our ten grantees and gives background on each of their projects: what the project is,

Spring 2016 Issue of Compass Now Available Read More »

Cure SMA Awards $300,000 Drug Discovery Grant to Charlotte Sumner, in Collaboration with Imago Pharmaceuticals

Leave a Comment / Front Page News, Research /

Cure SMA has awarded a $300,000 drug discovery grant to Charlotte Sumner, MD, at Johns Hopkins University, in collaboration with Imago Pharmaceuticals. The award is for the project, “Preclinical Development of a JNK Drug Candidate to Alter Disease Progression in SMA.” The Importance of Combination Therapies As the SMA drug pipeline has grown in breadth,

Cure SMA Awards $300,000 Drug Discovery Grant to Charlotte Sumner, in Collaboration with Imago Pharmaceuticals Read More »

Announcing an Evening of Fun at Disneyland Park

Leave a Comment / Conference, Front Page News /

Just added to this year’s conference schedule: Saturday Night at Disneyland Park! We’re very excited to announce that conference attendees will get to take part in this special evening of Disney fun, supported by Biogen. All registered participants will receive complimentary Saturday Disney Entrance Tickets to Disneyland Park. The ticket also incudes a special designated

Announcing an Evening of Fun at Disneyland Park Read More »

Scroll to Top